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Liver regeneration after two-thirds surgical partial
hepatectomy (PH) in rats treated with the pyrroliz-
idine alkaloid retrorsine is accomplished through the
activation, expansion, and differentiation of a pop-
ulation of small hepatocyte-like progenitor cells
(SHPCs). We have examined expression of the ma-
jor liver-enriched transcription factors, cytochrome
P450 (CYP) enzymes, and other markers of hepato-
cytic differentiation in SHPCs during the protracted
period of liver regeneration after PH in retrorsine-
exposed rats. Early-appearing SHPCs (at 3–7 days
after PH) express mRNAs for all of the major liver-
enriched transcription factors at varying levels com-
pared to fully differentiated hepatocytes. In addition,
SHPCs lack (or have significantly reduced) expression
of mRNA for hepatocyte markers tyrosine amino-
transferase and a-1 antitrypsin, but their expression
levels of mRNA and/or protein for WT1 and a-feto-
protein (AFP) are increased. With the exception of
AFP expression, SHPCs resembled fully differentiated
hepatocytes by 14 days after PH. Expression of AFP
was maintained by most SHPCs through 14 days after
PH, gradually declined through 23 days after PH, and
was essentially absent from SHPC progeny by 30 days
after PH. Furthermore, early appearing SHPCs lack
(or have reduced expression) of hepatic CYP proteins
known to be induced in rat livers after retrorsine
exposure. The resistance of SHPCs to the mitoinhibi-
tory effects of retrorsine may be directly related to a
lack of CYP enzymes required to metabolize retrors-
ine to its toxic derivatives. These results suggest that
SHPCs represent a unique parenchymal (less differen-
tiated) progenitor cell population of adult rodent liver
that is phenotypically distinct from fully differentiated
hepatocytes, biliary epithelial cells, and (ductular) oval
cells. (Am J Pathol 2000, 157:771–786)
Replacement of hepatocytes (and liver tissue mass) lost
to surgical resection (partial hepatectomy) or toxic injury
(necrosis) is typically achieved through the proliferation
of fully differentiated, normally quiescent hepatocytes
and biliary epithelial cells contained in the residual (via-
ble) tissue.1–4 Thus, fully differentiated hepatocytes can
be viewed as a unipotential progenitor cell for the gener-
ation of additional hepatocytes.5 However, certain forms
of toxic hepatocellular injury impair the replicative capac-
ity of hepatocytes, such as the modified Solt-Farber
hepatocarcinogenic model6–9 and the galactosamine
model of necrotic liver injury.10,11 In these models, the
liver parenchyma may be replaced via the proliferation
and differentiation of liver epithelial (ductular) stemlike
cells (oval cells).12,13 Oval cells are not activated during
liver repair in rodents if the mature residual hepatocytes
and biliary epithelial cells are capable of proliferating to
restore the normal liver mass and structure.11,14 There-
fore, two cell types of the adult rodent liver have been
recognized historically to possess “stemlike” character-
istics and are able to contribute to liver repair/regenera-
tion under different pathophysiological circumstances:
1) unipotential committed progenitor cells (differentiated
hepatocytes and biliary epithelial cells) and 2) multipo-
tential nonparenchymal progenitor cells (oval cells).
We have recently described the cellular responses
and time course for liver regeneration after surgical par-
tial hepatectomy (PH) in rats with retrorsine-induced hep-
atocellular injury.15 Similar to other models of chemical
liver injury,12,13 systemic exposure to retrorsine results in
a severe inhibition of the replicative capacity of fully
differentiated hepatocytes.15–19 When confronted with a
strong proliferative stimulus such as PH15–17,20 or hepa-
tocellular necrosis,21 retrorsine-injured hepatocytes that
are unable to complete mitosis arrest as nonproliferative
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giant cells (megalocytes). In this model, neither retrors-
ine-injured, fully differentiated hepatocytes nor oval cells
proliferate abundantly to contribute significantly to the
restoration of liver mass after PH. Instead, the entire liver
mass is reconstituted after PH through a novel cellular
response that is mediated by the emergence and rapid
expansion of a population of small hepatocyte-like pro-
genitor cells (SHPCs), which share some phenotypic
traits with fetal hepatoblasts, oval cells, and fully differ-
entiated hepatocytes but are morphologically and phe-
notypically distinct from all of these.15 SHPCs emerge
from all regions of the liver lobule after PH and are not
associated with modest oval cell outgrowths, suggesting
that SHPCs represent a novel cell population.15 SHPCs
morphologically most closely resemble fully differentiated
(but small) hepatocytes at early time points after PH,
perhaps indicating that SHPCs are a subset of retrorsine-
resistant hepatocytes and not a novel progenitor cell
population. However, the phenotype of SHPCs suggests
that they are in fact distinct from fully differentiated hepa-
tocytes, because a subset of SHPCs express the oval
cell/bile duct/fetal liver markers OC.2 and OC.5 through 5
days after PH.15 Coexpression of hepatocyte markers
and oval cell markers by early-appearing SHPCs sug-
gests that these cells either are not fully differentiated or
display a transitional phenotype similar to that expected
for a cell type between the bipotential hepatoblast (E14)
and the fetal hepatocyte (E18–E20).
In the current study, we have used a combined ap-
proach involving gene expression analysis of tissues iso-
lated using laser capture microdissection (LCM) and
in situ immunohistochemistry to study expression patterns
of mRNA and protein, respectively, in the earliest (least
differentiated) SHPCs that emerge after PH in retrorsine-
exposed rat livers. The results show that early-appearing
SHPCs (at 3–7 days after PH) expressed mRNA and/or
protein for all of the major liver-enriched transcription
factors, WT1, a-fetoprotein (AFP), and P-glycoprotein
(Pgp). In addition, compared to hepatocytes early-ap-
pearing SHPCs lacked (or had significantly reduced)
expression of mRNA for hepatocyte markers tyrosine
aminotransferase (TAT) and a-1 antitrypsin (a-1 AT). By
30 days after PH, expression patterns of all markers by
SHPCs mirrored that expected for fully differentiated
hepatocytes. AFP and WT1 protein were uniquely ex-
pressed by SHPCs during the early phase of liver regen-
eration, suggesting that these markers may be used to
identify the earliest progenitors of these cells. SHPCs that
emerge and proliferate during the early phase of liver
regeneration lack (or had reduced expression) of hepatic
cytochrome P450 proteins (CYPs) known to be induced
in rat livers after retrorsine exposure (CYP 2E1, CYP 1A2,
and CYP 3A1). The resistance of SHPCs to the mitoin-
hibitory effects of retrorsine may be directly related to a
lack of CYP enzymes required to metabolize retrorsine to
its toxic derivatives. The results of this study combine with
previous observations to strongly suggest that SHPCs
represent a unique parenchymal (less differentiated) pro-
genitor cell population of adult rodent liver.
Materials and Methods
Animals
Male German-strain Fischer 344 dipeptidylpeptidase IV
(DPPIV)-deficient rats were used in these studies. These
rats were bred and maintained in a colony at the Univer-
sity of North Carolina at Chapel Hill. The original breeders
were kindly provided by Douglas C. Hixson (Department
of Medical Oncology, Rhode Island Hospital, Brown Uni-
versity).
Retrorsine Administration and Partial
Hepatectomy
The retrorsine administration protocol15,16 and experi-
mental design15 were exactly as previously reported.
Six-week-old male littermate Fischer 344 rats (approx-
imately 100 g body weight) received two treatments of
retrorsine (30 mg/kg i.p.) 2 weeks apart. The retrorsine
working solution was prepared as described.15,16 Re-
trorsine (12,18-dihydroxysenecionan-11,16-dione;
b-longilobine; Sigma, St. Louis, MO) was added to
distilled water at 10 mg/ml and titrated to pH 2.5 with
1 N HCl to completely dissolve the solid. Subsequently,
the solution was neutralized using 1 N NaOH, and NaCl
was added for a final concentration of 6 mg/ml retrors-
ine and 0.15 mol/L NaCl (pH 7.0). The working solution
was used immediately after preparation. Two-thirds
surgical PH was performed on a subset of retrorsine-
exposed rats 5 weeks after the second treatment and
on unmanipulated control rats of similar age (13 weeks
old), essentially as originally described.22 At 0, 1, 3, 5,
7, 10, 14, 17, 23, and 30 days after PH (n 5 3– 6 per
time point), portions of liver tissue were fixed in 10%
neutral buffered formalin processed for RNA or snap-
frozen in liquid nitrogen and then placed into embed-
ding medium (OCT) for preparation of cryosections for
use in LCM. All studies involving animals were carried
out in accordance with federal and state guidelines put
forth by the National Institutes of Health and the Insti-
tutional Animal Care and Use Committee of the Univer-
sity of North Carolina at Chapel Hill.
RNA Isolation and Amplification
Total liver RNA was obtained from retrorsine-exposed
and control rats at t 5 0 and 30 days after PH as previ-
ously described.23,24 Liver tissue was solubilized in an
RNA extraction buffer consisting of 4 mol/L guanidinium
isothiocyanate, 25 mmol/L sodium citrate, 0.1 mol/L
b-mercaptoethanol, and 0.5% N-lauroyl-sarcosine. The
lysate was placed on a cushion of 5.7 mol/L cesium
chloride containing 25 mmol/L sodium acetate and cen-
trifuged at 36,000 rpm in a Beckman SW40 rotor for 18
hours at 24°C.
RNA was obtained from fully differentiated hepato-
cytes (megalocytes) and SHPCs, using a PixCell laser
capture microscope with an infrared diode laser (Arctu-
rus Engineering, Santa Clara, CA), essentially as de-
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scribed25–29 and shown in Figure 1. Portions of snap-
frozen liver from retrorsine-exposed rats at 5, 7, 14, and
30 days after PH (n 5 3 rats per time point) were sec-
tioned at 6 mm onto uncharged slides. Cryosections were
fixed in cold 70% EtOH for 1 minute. and rehydrated for
30 seconds in phosphate-buffered saline (PBS) (136
mmol/L NaCl, 2.7 mmol/L KCl, 10 mmol/L Na2HPO4, and
1.76 mmol/L KH2PO4, pH 7.2) prepared using diethyl
pyrocarbonate-treated water. After a brief (1–2 minutes)
counterstain in Mayer’s hematoxylin (Sigma), sections
were dehydrated through a series of alcohol solutions
(70%, 95%, and 100%) for 1 minute. each, cleared in
xylene, and allowed to completely dry at room tempera-
ture. Microdissection immediately followed tissue prepa-
ration. Approximately 50 cells of each type were morpho-
logically identified, microdissected, and solubilized in
RNA extraction buffer. To ensure the absence of nonspe-
cific transfer of tissue, we placed the microdissection cap
on the tissue without firing the dissecting laser. RNA was
extracted using a phenol/chloroform-based procedure
based on the Stratagene Microisolation protocol.30–33 Dou-
ble-stranded cDNA was synthesized from extracted RNA
(Gibco cDNA Synthesis Kit; Life Technologies, Rockville,
MD), exactly per the manufacturer’s instructions, with the
following exception: first-strand synthesis was initiated us-
ing a T7 promoter-oligo(dT) primer as described.34 The T7
promoter-oligo(dT) primer (59-TCTAGTCGACGCCCAGT-
GAATTGTAATACGACTCACTATAGGGCGT21239) was
synthesized by the UNC Oligonucleotide Synthesis Core
Facility, as described.34 After cDNA synthesis, T4 DNA
polymerase (Life Technologies) was added to the reaction
mixture and incubated at 16°C for 10 minutes to produce
completely blunt ends. Subsequent RNA amplification
was achieved using the Ampliscribe T7 Transcription kit
(Epicentre Technologies, Madison, WI) exactly per the
manufacturer’s recommended protocols. All RNA samples




To perform reverse transcriptase-polymerase chain reac-
tion (RT-PCR), 2 mg total whole liver RNA or T7-amplified
RNA was reverse-transcribed into cDNA, using Gibco
Superscript II Reverse Transcriptase (Life Technologies),
for 60 minutes at 42°C, and oligo(dT) as the primer ac-
cording to standard procedures.35 The sequence of all
PCR primers is summarized in Table 1. The PCR primers
used to amplify portions of mRNA from CYP reductase
and CYPs 1A1, 1A2, 2B1/2, 2E1, and 3A1 were synthe-
sized as described.36 These PCR primers are comple-
Figure 1. LCM-facilitated isolation of homogeneous cell populations from
retrorsine-exposed rat livers after PH. A-C: Microdissection of SHPCs on fixed
tissue cryosections from retrorsine-exposed rat liver 5 days after PH. SHPC
cell clusters that are identified based on morphological criteria (A) are
overlaid with a cap coated with a plastic polymer and targeted for microdis-
section with a laser to melt the plastic surrounding the cells of interest to fuse
them to the surface. Only targeted cells are removed from the tissue (B) and
adhere to the cap when lifted from the tissue section (C). * Point of reference
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mentary to sequences in the mRNA that correspond to
sequences of intron/exon boundaries of the respective
CYP genes to prevent amplification from genomic DNA
template. Oligonucleotide primers for all other mRNAs
were designed based on the known cDNA sequence
(GenBank). All primers were generated by the UNC Oli-
gonucleotide Synthesis Core Facility. Verification of equal
template concentration between samples was accom-
plished using primers that amplify a portion of actin
mRNA (Research Genetics, Huntsville, AL). Amplified
PCR products were electrophoresed on 2% agarose gels
and visualized using ethidium bromide staining.
Immunohistochemistry
Markers of hepatocytes and hematopoietic stem cells
were examined on 6-mm formalin-fixed, paraffin-embed-
ded sections and 6-mm cryosections from retrorsine-ex-
posed and control rats 1, 3, 5, 7, 10, 14, 17, 23, and 30
days after PH and from control and retrorsine-exposed
rats not surgically manipulated. Hepatocyte markers
were identified using antibodies to AFP, Pgp (Santa Cruz
Biochemicals, Santa Cruz, CA); cytokeratin 18 (CK18)
(Dako, Carpinteria, CA); CYP reductase, CYP 1A1, CYP
2B1, CYP 2E1 (Gentest, Woburn, MA); CYP 4A (Affinity
Table 1. Primer Sequences Used for RT-PCR Analysis of Gene Expression in Retrorsine-Exposed Rat Hepatocytes and SHPCs





CYP reductase GAGCACTTCAATGCCATGGGCAAG 65 597
GATGTCCAGGTAGTAGGTGAGGGCC
CYP 1A1 GATGCTGAGGACCAGGAAGACCGC 65 679
CAGGAGGCTGGACGAGAATGC
CYP 1A2 CTTGGAGAAGCGTGGCCAGG 55 664
CTACAAAGACAACGGTGGTCT
CYP 2B1/2* CCAAGCCGTCCACGAGACTT 60 380/404*
TTGGGAAGCAGGTACCCTC
CYP 2E1 CTGCCCCCAGGACCTTTTCCC 65 847
ATCAGGAGCCCATATCTCAGAGTTGTCCTGGTGGTCTC
CYP 3A1 CAGCTCTCACACTGGAAACCTGGG 60 689
CTCATATATTTGGGGTGAGGAATGG
CYP 4A3 TCGAGGATCTAAACAACCTGAC 60 573
GGTTGTGATACCTTTGGGTATGG
C/EBP-a TTCCAGATCGCACACTGCCC 65 404
TGACCAAGGAGCTCTCAGGC
C/EBP-b TGACCAAGGAGCTCTCAGGC 65 419
ACCCACCACCACACACAACCC
C/EBP-g CACTGGACAGCTGGTTAGCC 60 399
TCTCGACGTGACCTGATGGG
HNF-1a AGACACCAACCTCAGCACCC 65 463
AGACACCTCAGAGCCATCCC
HNF-1b CCGTTCTTGGAAAATGGTGTCCAAGC 60 235
ATGGGAGGAGTGTCATAGTCGTCG
HNF-3a TGCAGTACTCTCCTTACGGC 60 714
GGGGAAACTTGTTTAGCTGGG
HNF-3b GCCCAGTCACGAACAAAGCC 60 686
GGAACTCTGGCATTCTAGCC
HNF-3g AACTGAAGTTGGATGCGCCC 60 476
ATATGTCCTCCGACATCGCG
HNF-4 TCTACAGAGCATTACCTGGC 60 614
TGAGGGGAAGATGAAGACGG
HNF-6 GACAAATGGCAGGACGAGGG 60 681
AGCGTACTGGTTTAGGTGCC
WT1 GTCAGAAAAAGTTTGCGCGG 55 200
CCATCATGTCCTTTTGTAGG
a-Fetoprotein CAGTGAGGAGAAACGGTCCG 60 252
ATGGTCTGTAGGGCTCGGCC
a-1-Antitrypsin ATGGATTACCTGGGCAACGC 60 398
TTTTCCCACAAAGAGGGGGC
Albumin AAGGCACCCCGATTACTCCG 60 608
TGCGAAGTCACCCATCACCG
Transferrin CCTGACAAAACGGTCAAATGGTGC 60 251
TAAAAACTCTGCTGCCACAGGC
Tyrosine aminotransferase (TAT) TACTCAGTTCTGCTGGAGCC 65 471
GCAAAGTCTCTAGAGAGGCC
*The cytochrome P450 mRNA isoforms 2B1 and 2B2 have substantial homology, differing mainly in an additional 24 bp in 2B2. Therefore, these
primers amplify both isoforms and amplicons can be distinguished by size on agarose gels.
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Bioreagents, Golden, CO); and CYP 3A1 (Oxford Bio-
medical Research, Oxford, MI) in addition to WT1 (Santa
Cruz Biochemicals). Hematopoietic stem cell markers
were identified using antibodies to Thy-1 (Pharmingen,
San Diego, CA) and CD34 (Research Diagnostics,
Flanders, NJ). Immunostaining of CK18, Thy-1, and CD34
was performed on 6-mm liver cryosections fixed for 10
minutes in cold 4% paraformaldehyde. All other immuno-
staining was performed on 6-mm paraffin sections. Indi-
rect immunoperoxidase analysis was performed on par-
affin sections that were cleared with xylene and passed
through a graded series of alcohols ending with a short
incubation (15 minutes) in PBS to fully rehydrate tissue
sections. Detection of primary antibodies was accom-
plished using the avidin/biotin peroxidase system (Vec-
tastain Elite Kit; Vector, Burlingame, CA). Endogenous
peroxidase activity was quenched using 0.3% H2O2 in
PBS. Blocking of nonspecific activity was accomplished
by a 30-minute incubation in buffer containing serum of
the secondary antibody species. When necessary, anti-
genic unmasking was accomplished by either incubation
in 0.1% porcine trypsin for 20 minutes (for WT1, Pgp,
CYPs 1A1, 2B1, 2E1, and CYP reductase) or by boiling in
a 0.01 mol/L citrate buffer consisting of 1.8 mmol/L citric
acid and 8.2 mmol/L sodium citrate (pH 6.0) for 10 min-
utes (for CYP3A1 and AFP). Primary antibodies were
diluted by 1:200 (1:100 for AFP) in PBS and incubated on
tissue sections for 30 minutes. Biotinylated secondary
antibodies (Sigma) were diluted by 1:100 and applied to
tissue sections for 30 minutes. Antibody complex was
visualized using diaminobenzidine (DAB Kit; Vector) with
Mayer’s hematoxylin counterstain. Immunoperoxidase
analysis of 4% paraformaldehyde-fixed cryosections in-
corporated an additional step to block endogenous avi-
din/biotin binding sites (Avidin/Biotin Blocking Kit; Vec-
tor). Primary antibodies were diluted by 1:100 in PBS and
incubated on tissue sections for 30 minutes. Immunoper-
oxidase analysis was performed as described. Negative
controls for all immunostaining reactions consisted of
replacement of the primary antibody with PBS. All images
were captured using a Nikon FXA microscope and color
transparency film.
Densitometry and Statistical Analysis
RT-PCR was quantitated by a densitometric-based anal-
ysis of digitally captured agarose gels, using Kodak Dig-
ital Science 1D software (version 2.02). A two-tailed un-
paired t-test was used to generate P values and
determine the significance of all quantified differences in
pixel density. GraphPad Prism software (version 2.01)
was used for all calculations.
Results
Expression of mRNA for Liver-Enriched
Transcription Factors by SHPCs
No RNA was obtained from preparations where we
placed the microdissection cap on the tissue without
firing the laser (data not shown). The results of RT-PCR
analysis of liver-enriched transcription factor mRNA ex-
pression in retrorsine-injured, growth-arrested megalo-
cytes and SHPCs from the livers of retrorsine-exposed
rats after PH are summarized in Figure 2. Expression
levels of HNF-1a mRNA were similar between SHPCs and
megalocytes at all time points examined (Figure 2A).
However, levels of HNF-1b mRNA were consistently and
significantly (P 5 0.029) lower in SHPCs 5 days after PH
than in megalocytes at the same time point (Figure 2B).
Conversely, levels of HNF-3a mRNA are significantly
(P 5 0.012) higher in SHPCs than in megalocytes at this
time (Figure 2C). Levels of HNF-3b and HNF-3g mRNA
remained consistent between megalocytes and SHPCs
at all time points (Figure 2, D and E, respectively). Ex-
pression levels of HNF-4 mRNA were significantly ele-
vated in SHPCs compared to megalocytes 5, 7, and 14
days after PH (P 5 0.037, P 5 0.031, and P 5 0.042,
respectively) (Figure 2F), whereas levels of HNF-6 mRNA
remained consistent between the two cell types across all
time points (Figure 2G). At 5 and 7 days after PH, mRNA
levels of C/EBP-a were significantly lower (P 5 0.002 and
P 5 0.015, respectively) (Figure 2H), and mRNA levels of
C/EBP-b (Figure 2I) and C/EBP-g (Figure 2J) were signif-
icantly higher in SHPCs compared to megalocytes at
similar time points (P 5 0.027 and P 5 0.019, respec-
tively, for C/EBP-b; P 5 0.037 and P 5 0.044, respec-
tively for C/EBP-g).
Expression of mRNA for Hepatocyte Markers by
SHPCs
The results of RT-PCR analysis of hepatocyte marker
mRNA expression in retrorsine-injured, growth-arrested
megalocytes and SHPCs microdissected from the livers
of retrorsine-exposed rats after PH are summarized in
Figure 3. SHPCs in expanding clusters had significantly
lower levels of CYP 2E1 mRNA 5 and 7 days after PH
(P 5 0.026 and P 5 0.021, respectively) compared to
surrounding megalocytes on the same tissue section
(Figure 3A). At 14 and 30 days after PH, the amount of
CYP 2E1 mRNA in SHPCs increased dramatically to lev-
els approaching that observed in surrounding megalo-
cytes. Differences between the levels of CYP 2E1 mRNA
in SHPCs and megalocytes at these later time points
were not significantly different (P 5 0.062 and P 5 0.085,
respectively), although SHPCs never expressed a level of
CYP 2E1 mRNA that equaled that of the megalocytes at
any time point. SHPCs also had significantly lower levels
of CYP 3A1 mRNA 5, 7, and 14 days after PH (P , 0.001)
compared with megalocytes (Figure 3B). CYP 3A1 mRNA
levels in SHPCs 30 days after PH were indistinguishable
from that of surrounding megalocytes. Five days after PH,
SHPCs did not express mRNA for TAT (Figure 3C). TAT
mRNA expression was initiated in these cells by 7 days
after PH, albeit at levels significantly (P 5 0.036) lower
than those of megalocytes. By 14 days after PH, TAT
mRNA expression levels in SHPCs resembled those
found in megalocytes. We did not detect a-1 antitrypsin
(a-1 AT) mRNA in SHPCs at 5 or 7 days after PH (Figure
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3D). However, by 14 days after PH, levels of a-1 AT
mRNA in SHPCs were statistically (P . 0.05) indistin-
guishable from those in megalocytes at the same time
point. Low levels of AFP mRNA were detected in mega-
locytes only 5 days after PH (Figure 3E). At the same time
point, significantly higher levels of AFP mRNA were found
in SHPCs (P 5 0.0002). SHPCs continued to express
detectable AFP mRNA through 14 days after PH, al-
though the relative expression levels at this time were
significantly reduced compared with 5 and 7 days after
PH (P 5 0.0061 and P 5 0.025, respectively). WT1 mRNA
was not found in megalocytes at any time point (Figure
3F). However, high levels of WT1 mRNA were found in
SHPCs 5 days after PH and were present at detectable
levels in these cells 7 days after PH. WT1 message was
rarely present in SHPCs at 14 days after PH and was
never present at 30 days after PH. Levels of mRNA for
CYP 2B1/2, CYP 4A3, CYP 1A2, CYP reductase, albumin,
and transferrin were similar in SHPCs and megalocytes at
all time points examined (Figure 3, G–L, respectively).
Figure 2. RT-PCR analysis of liver-enriched transcription factor expression in expanding clusters of SHPCs after PH in the livers of retrorsine-exposed rats. Portions
of message were PCR-amplified using primers and annealing temperatures shown in Table 1 for HNF-1a, 463 bp (A); HNF-1b, 235 bp (B); HNF-3a, 714 bp (C);
HNF-3b, 686 bp (D); HNF-3g, 476 bp (E); HNF-4, 614 bp (F); HNF-6, 681 bp (G); C/EBP-a, 404 bp (H); C/EBP-b, 419 bp (I); and C/EBP-g, 399 bp (J). M: 100-bp
DNA ladder. (2), Negative control consisting of substitution of water for template in the PCR reaction. Lanes 1–4: RNA from hepatic megalocytes 5, 7, 14, and
30 days, respectively, after PH in retrorsine-exposed rats. Lanes 5–8: RNA from SHPCs 5, 7, 14, and 30 days, respectively, after PH in retrorsine-exposed rats.
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Figure 3. RT-PCR analysis of hepatocyte marker expression in expanding clusters of SHPCs after PH in the livers of retrorsine-exposed rats. Portions of message
were PCR-amplified using primers and annealing temperatures shown in Table 1 for CYP 2E1, 847 bp (A); CYP 3A1, 689 bp (B); TAT, 471 bp (C); a-1 AT, 398
bp (D); AFP, 252 bp (E); WT1, 200 bp (F); CYP 2B1/2, 380/404 bp (G); CYP 4A3, 573 bp (H); CYP 1A2, 664 bp (I); CYP reductase, 597 bp (J); albumin, 608
bp (K); and transferrin, 251 bp (L). M: 100-bp DNA ladder. (2), Negative control consisting of substitution of water for template in the PCR reaction. Lanes 1–4:
RNA from hepatic megalocytes 5, 7, 14, and 30 days, respectively, after PH in retrorsine-exposed rats. Lanes 5–8: RNA from SHPCs 5, 7, 14, and 30 days after
PH in retrorsine-exposed rats, respectively. To demonstrate equal template concentrations, amplification of actin mRNA for each sample is shown below A,
corresponding to samples in respective lanes.
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mRNA Expression in Whole Liver Preparations
To show that retrorsine exposure alone does not alter the
expression of specific genes in rat liver that appear to be
differentially expressed by proliferating/differentiating
SHPCs in this model, we examined levels of mRNA for
TAT, a-1 AT, WT1, AFP, and CYP 2E1 in whole liver
preparations from control and retrorsine-exposed rats
before PH and 30 days after PH. Although WT1 message
is not normally expressed by hepatocytes,37 we ob-
served trace levels of WT1 message in all whole liver
mRNA preparations, likely reflecting contributions from
the mesothelium.38 AFP mRNA was detected in all whole
liver mRNA preparations at consistently higher levels
than in microdissected megalocyte preparations, possi-
bly reflecting contributions from cells of the portal triads
and periductular cells.17,39,40 Abundant levels of mRNA
for TAT, a-1 AT, and CYP 2E1 were observed in all
preparations. However, expression levels did not signifi-
cantly differ (P . 0.05) between any groups for any
mRNA examined (data not shown).
Immunohistochemical Detection of CYP and
Pgp Protein in SHPCs
Expression of CYP protein by SHPCs in retrorsine-ex-
posed rats after PH is summarized in Figure 4. Similar to
previous observations in normal rat livers,41 we detected
CYP protein in all hepatocytes of resting and regenerat-
ing livers of control rats, with higher levels located in
pericentral and midlobular regions (data not shown).
Consistent with RT-PCR data, clusters of SHPCs 5 days
after PH had substantially reduced levels of CYP 3A1
protein compared with surrounding megalocytes (Figure
4A). The majority of SHPCs in these early clusters had
undetectable CYP 3A1 protein, although approximately
10–15% displayed CYP 3A1 expression levels that were
similar to those of fully differentiated hepatic megalo-
cytes. At 14 days after PH (Figure 4B), most SHPCs
continued to demonstrate reduced levels of CYP 3A1,
with approximately 20–25% now expressing this protein
at levels comparable to those of megalocytes. Between
14 and 23 days after PH, CYP 3A1 expression was seen
in increasing numbers of SHPCs, and by 30 days after
PH, CYP 3A1 protein levels and distribution resembled
those of normal liver (data not shown). At 3 days after PH,
most SHPCs had abundant CYP 2B1/2 protein levels that
were indistinguishable from those of surrounding mega-
locytes (Figure 4C) or control hepatocytes from normal or
regenerating liver (data not shown). Expression of CYP
2B1/2 by SHPCs did not change at time points later than
3 days after PH (data not shown). Conversely, 3 days
after PH, SHPCs were largely negative for CYP 1A2 (data
not shown) and CYP 2E1 (Figure 4D). Approximately 75%
of all SHPCs at this time point lacked detectable levels of
CYP 2E1, 20% expressed low but detectable levels, and
5% had protein levels that resembled those of surround-
ing megalocytes (Figure 4D) or hepatocytes from normal
or regenerating liver (data not shown). By 5 days after
PH, approximately 50% of SHPCs lacked CYP 2E1 pro-
tein, and nearly 25% had normal expression levels (data
not shown). By 7 days after PH, nearly all SHPCs had
levels of CYP 2E1 protein that were indistinguishable from
those of surrounding megalocytes (data not shown). The
temporal pattern of CYP 1A2 protein expression by
SHPCs was very similar to that observed for CYP 2E1
(data not shown). We examined serial sections from ret-
rorsine-exposed rats 5 days after PH for the expression of
CYP 2B1/2 and CYP 2E1 (Figure 4, E and F, respectively)
to explore the onset of expression of these two CYP
isoforms in proliferating/differentiating clusters of SHPCs.
In Figure 4, E and F, note that SHPCs are either positive
for both CYPs (rightmost arrow), negative for both (left-
most arrow), or CYP 2B1-positive and CYP 2E1-negative
(uppermost arrow). This observation strongly suggests
that CYP 2B1/2 expression precedes that of CYP 2E1 in
SHPCs. Consistent with RT-PCR analysis, protein expres-
sion levels of CYP 4A, CYP 1A2, and CYP reductase by
SHPCs at all time points after PH were comparable to
those of surrounding megalocytes and hepatocytes from
resting and regenerating control livers (data not shown).
Pgp is the product of the MDR1 gene and is the most
extensively studied member of the MDR family shown
thus far to be responsible for drug resistance in certain
tumor cells.42 In the liver, Pgp is weakly expressed on the
(apical) bile canaliculi surface of many fully differentiated
adult hepatocytes.43 Our observations of control rat livers
were consistent with this observation (data not shown). In
control livers after PH, there was a moderate and tran-
sient increase in the levels of canalicular Pgp through 3
days after PH that normalized by 5 days after PH (data
not shown). This effect was similar, yet more pronounced
on megalocytes in retrorsine-exposed rat livers 5 days
after PH (Figure 5A) and persisted though 7 days after PH
(data not shown). In control livers, Pgp was always local-
ized to the canalicular surface of hepatocytes and was
never found to exist predominately in the cytosol (data
not shown). However, in retrorsine-exposed rats in the
absence of PH, there were rare cells that were positive for
cytoplasmic Pgp (data not shown). Likewise, individual
cells in SHPC clusters at 3 days after PH moderately
expressed cytoplasmic Pgp (Figure 5B) that began to
localize to the canalicular surface by 5 days after PH
(Figure 5A). At all time points later than 5 days after PH,
Figure 4. Immunohistochemical detection of cytochrome P450 isoforms in livers of retrorsine-exposed rats after PH. A and B: Indirect immunoperoxidase analysis
of CYP 3A1 on liver sections from retrorsine-exposed rats 5 and 14 days after PH, respectively. C and D: Indirect immunoperoxidase analysis of CYP 2B1 and CYP
2E1, respectively, of tissue sections from retrorsine-exposed rats 3 days after PH. E and F: Indirect immunoperoxidase analysis of CYP 2B1 and CYP 2E1,
respectively, on serial sections from retrorsine-exposed rats 5 days after PH. A subset of SHPCs in expanding clusters initiates expression of CYP 3A1 5 days after
PH (A), although the vast majority of SHPCs still have undetectable (or very low) protein levels of this CYP isoform 14 days after PH (B). Nearly all SHPCs are
CYP 2B1-positive 3 days after PH (C), and most are CYP 2E1-negative at the same time point (D). Serial section immunohistochemical analysis of CYP 2B1 (E)
and CYP 2E1 (F) on tissue sections 5 days after PH confirms that the initiation of CYP 2B1 expression precedes CYP 2E1 expression. E and F: Note that cells are
either positive for both CYPs (rightmost arrow), negative for both (leftmost arrow), or CYP 2B1-positive and CYP 2E1-negative (uppermost arrow). Bar,
50 mm. Arrows, small hepatocyte-like cells. * Reference point.
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the expression of Pgp by SHPC progeny declined and
mirrored that of surrounding megalocytes (data not
shown).
Immunohistochemical Detection of AFP Protein
in SHPCs
Previous studies have documented fetal-form AFP mRNA
in rare hepatocytes (approximately 1 in 20,000 cells) of
normal rats.40 Consistent with these observations, we
observed rare examples of hepatocytes that were in-
tensely AFP-positive in control livers in the absence of PH
and were indistinguishable morphologically from the sur-
rounding hepatocytes. Individual AFP-positive cells in
these livers were found in 5% (range 1–9%) of liver lob-
ules. We also observed trace levels of AFP in many
parenchymal hepatocytes, inasmuch as the AFP anti-
body we used for these studies shows minor cross-reac-
tivity with the weakly expressed adult form of AFP.40,44
Similar to previous observations of AFP mRNA expres-
sion in normal rat livers after PH,17 in control livers
through 3 days after PH, we observed intensely AFP-
positive cells with a slight increase in prevalence (8 6 3%
of liver lobules), typically found closely spaced (usually
as doublets), suggestive of one or two rounds of replica-
tion. After 3 days after PH, the relative numbers of AFP-
positive cells in control rat livers had returned to pre-PH
frequencies. AFP-positive cells in retrorsine-exposed rat
livers were present at approximately the same frequency
as in control livers (6 6 4% of liver lobules). However, in
contrast to observations in control rats, AFP-positive cells
in retrorsine-exposed livers after PH physically resem-
bled, yet were morphologically distinct from, surrounding
hepatocytes. They were moderately smaller than sur-
rounding hepatocytes (ie, future megalocytes) and highly
vacuolated and possessed scant cytoplasm. At 1 day
after PH in retrorsine-exposed rats, only these cells ex-
pressed abundant AFP (Figure 5C). Consistent with RT-
PCR data (Figure 3E), growth-arrested megalocytes were
weakly to moderately AFP-positive through 5 days after
PH (Figure 5D), after which they expressed trace
amounts of AFP at levels similar to those of control rats
(data not shown). During the same time period, small cell
clusters previously determined to consist of early-ap-
pearing SPHCs15 expressed substantially higher levels of
AFP, and over 90% of SHPCs were AFP-positive at 5 days
after PH (Figure 5D). AFP-positive hepatocyte-like cells at
1 day after PH morphologically resembled cells forming
early clusters of SHPCs at 5 days after PH,15 although the
current study did not produce evidence of a direct lin-
eage relationship between these two cell types. Rapidly
proliferating SHPCs remained intensely AFP-positive
through 14 days after PH (Figure 5E) and gradually
ceased expression of this protein though 23 days after
PH (Figure 5F). At 30 days after PH, when the livers of
retrorsine/PH rats were essentially indistinguishable from
those of controls,15 the differentiated progeny of SHPCs
were AFP-negative, and the number of AFP-positive cells
detected was indistinguishable from that observed in
unmanipulated control rats (data not shown). AFP-posi-
tive oval cells in retrorsine-exposed rat livers were ex-
tremely rare at any time point and, as in previous obser-
vations,15 were never associated with proliferating
clusters of SHPCs (data not shown).
Immunohistochemical Detection of WT1
Protein, CK18, and Hematopoietic Stem Cells
Markers in SHPCs
The protein product of the WT1 gene is a multiple-func-
tion tumor suppressor whose aberrant expression has
been implicated in the formation of childhood nephro-
blastomas (Wilms’ tumors).45 Although WT1 mRNA is not
normally detected in adult rat hepatocytes,37 abundant
WT1 mRNA and/or protein can be found in liver mesothe-
lial cells and cultured rat liver epithelial (non-parenchy-
mal) cells (WB-F344 cells, BRL-3A cells, and LE/6
cells).38,46 Consistent with these observations, we de-
tected WT1 protein in liver mesothelial cells on fixed liver
tissue sections, but did not detect WT1 protein in hepa-
tocytes of control and retrorsine-exposed rats in the ab-
sence of PH or in control rat livers at any time after PH
(data not shown). However, in retrorsine-exposed rat liv-
ers at 1 day after PH there were rare parenchymal cells
(that most resembled hepatocytes morphologically) that
stained intensely for nuclear-localized WT1 (Figure 5G).
Expression of WT1 was maintained by a substantial sub-
set (.80%) of verified SHPCs (WT1 protein is localized in
the nucleus in approximately 5%) at 3, 5 (Figure 5H), and
7 days after PH, was gradually lost through 10 days after
PH, and returned to undetectable levels (similar to those
of control and retrorsine-exposed rats in the absence of
PH) by 14 days after PH (data not shown). Oval cells in
Figure 5. Immunohistochemical detection of hepatocyte markers in livers of retrorsine-exposed rats after PH. A and B: Indirect immunoperoxidase analysis of
Pgp on liver sections from retrorsine-exposed rats 5 and 3 days after PH, respectively. C–F: Indirect immunoperoxidase analysis of AFP on liver sections from
retrorsine-exposed rats 1, 5, 14, and 23 days after PH, respectively. G and H: Indirect immunoperoxidase analysis of WT1 on liver sections from retrorsine-exposed
rat 1 and 5 days after PH. In hepatocytes and SHPCs 5 days after PH (A), Pgp is localized to the bile canaliculi. However, a subset of SHPCs express cytoplasmic
Pgp 3 days after PH (B). Small, single AFP-positive hepatocyte-like cells in retrorsine-exposed rat livers are present 1 day after PH (C). Rapidly proliferating SHPCs
5 days after PH form AFP-positive clusters (D). Most SHPCs continue to strongly express AFP through 14 days after PH (E). By 23 days after PH, most SHPCs have
ceased expression of AFP, and few AFP-positive cells remain (F). Rare growth-arrested megalocytes are weakly to moderately AFP-positive through 5 days after
PH, after which they express trace amounts of AFP at levels similar to those of control rats (the AFP antibody weakly cross-reacts with the adult form of AFP).
WT1 protein is localized to the nucleus of rare liver parenchymal cells in retrorsine exposed rats 1 day after PH (G) and is weakly expressed 5 days after PH by
proliferating SHPCs and is not expressed by fully differentiated hepatic megalocytes (designated by long arrows) (H). WT1 protein is localized to the nucleus
of a small fraction (approximately 5%) of proliferating SHPCs (small arrows, H). Bar, 50 mm. Small arrows, small hepatocyte-like cells. Large arrows (H),
growth-arrested, fully differentiated hepatocytes. Note: The inset of F shows a higher magnification of a representative AFP-positive hepatocyte from a different
tissue section 23 days after PH.
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retrorsine-exposed rat livers did not express WT1 protein
at any time (data not shown).
Liver progenitor cells (oval cells) activated in other
models of liver injury expressed the hematopoietic stem
cell markers CD3447 and Thy-1.48 Furthermore, cytoplas-
mic Pgp is highly expressed by certain immature cell
types (such as hematopoietic stem cells).49 Based on
these two observations, we examined SHPCs for the
expression of CD34 and Thy-1. CD34 has been shown to
be expressed in normal liver by endothelial cells of large
hepatic vessels and bile ductular epithelial cells.47,50 Our
observations in retrorsine-exposed and control livers
both with and without PH were consistent with these
previous findings (data not shown). However, at no time
after PH were cells making up SHPC clusters positive for
CD34 (data not shown). Oval cells that undergo limited
proliferation after PH in the retrorsine model15 displayed
a heterogeneous pattern of CD34 expression (data not
shown). Thy-1 is not normally observed in the adult liver
but is expressed by oval cells in the 2-acetylaminoflu-
orene/PH model of liver injury.48 In the current study, we
did not detect expression of Thy-1 on any cell type in the
livers of any experimental rats (data not shown).
We examined SHPCs for the expression of CK18 be-
cause oval cells, hepatocytes, and bile duct epithelial
cells express this cytokeratin.51–53 In the current study,
we detected CK18 in bile duct cells in the livers of all
experimental rats (data not shown). In retrorsine-exposed
rats 5 days after PH and at all times thereafter, CK18 was
expressed by both oval cells and SHPCs (data not
shown).
Discussion
We have examined temporal patterns of mRNA and pro-
tein expression in proliferating and differentiating clusters
of SHPCs that emerge after PH in retrorsine-exposed
rats. A combined approach was used that employed the
relatively new technique of LCM25,27,28,31,33,34,54 to iso-
late with absolute purity small clusters of SHPCs from
fixed tissue sections. Dissected cells were used to obtain
mRNA for use in RT-PCR gene expression analysis to
complement immunohistochemical analysis of fixed tis-
sue sections. This experimental design facilitates direct
examination of homogeneous cell populations for the
expression of various markers of differentiation. Although
early-appearing SHPCs have some antigenic determi-
nants in common with fully differentiated hepatocytes,
bile duct epithelia, and other liver progenitor cell types
(oval cells), it appears that they possess an overall phe-
notype that would distinguish them from each of these.15
However, the ultimate precursor cell for SHPCs has not
been identified in normal (or retrorsine-exposed) liver.
Even though no firm evidence has been found to date
establishing a direct lineage relationship between oval
cells and SHPCs,15 this possibility still cannot be com-
pletely excluded. SHPCs proliferate extensively after PH
in retrorsine-exposed rats while simultaneously acquiring
the panoply of markers that are characteristic of fully
differentiated hepatocytes. Yet, the molecular mecha-
nism by which SHPCs, and not fully differentiated hepa-
tocytes, are able to escape the proliferative block im-
posed by retrorsine and expand in number after PH is not
known. The results of the current study 1) provide evi-
dence that further distinguishes SHPCs as a cell type that
is phenotypically distinct from other parenchymal and
progenitor cell types of the rodent liver, 2) describe two
unique markers expressed by SHPCs that could poten-
tially be used to identify SHPC precursors in normal ro-
dent liver, and 3) suggest that SHPCs escape the mito-
inhibitory effects of retrorsine because they lack or have
reduced expression of one or more of the CYP isozymes
necessary to produce toxic metabolic derivatives of
retrorsine.
The onset (and loss) of various markers of hepatocyte
differentiation by early-appearing SHPCs as they prolif-
erate and differentiate suggest that these cells display a
phenotype resembling that expected for a transitional cell
type between the bipotential hepatoblast (E14) and the
fetal hepatocyte (E18–E20) (Figure 6). SHPCs at 5 days
after PH most resemble fully differentiated hepatocytes
morphologically. Therefore, it is significant that these
cells express (at varying levels) mRNA for all of the major
families of liver-enriched transcription factors normally
expressed by adult hepatocytes. At 5 days after PH,
SHPCs have abundant mRNA for the liver “establishment
factors” HNF-1a, HNF-3, and HNF-4 (see Figure 2, A,
C-F, respectively) proposed by Lai and Darnell55 to be
important for liver development before embryonic day 16
(E16). As in embryonic liver development,56 mRNA levels
for HNF-3a and HNF-4 in (maturing) SHPCs decrease 5
Figure 6. Expression of protein and/or mRNA for markers of differentiation
in developing embryonic rat liver. Early-appearing SHPCs express a pheno-
typic profile that resembles that expected for a transitional cell type that is
between the bipotential hepatoblast (E14) and the fetal hepatocyte (E18–
E20). Markers of differentiation initiated in rat livers on or by E14 expressed
in bipotential hepatoblasts, and at various times afterward in hepatocyte-
determined cells culminating in birth, are summarized from the published
literature.13,41,51,56,59–61,63–67,91,92 Expression of markers of differentiation
by SHPCs 5 days after PH (contained within the box) is summarized from the
results of the current study and previously published results.15 The 1/2
designation refers to either the presence or the absence of mRNA and/or
protein for the marker on subsets of SHPC populations 5 days after PH and
does not indicate relative expression levels within populations positive for
the marker. SHPC marker expression without the 1/2 designation implies
uniform positive or negative expression for all observed SHPCs or that the
extent of expression in SHPC subpopulations is not known (eg, for RT-PCR-
derived data).
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days after PH, at the time when mRNA levels for HNF-1b
increase. The combined results of numerous studies
have shown that the transcription factor C/EBP-a has
reciprocal mRNA expression levels compared to
C/EBP-g and C/EBP-b in actively regenerating liver after
PH.57,58 In response to PH, levels of C/EBP-a mRNA are
dramatically decreased, whereas levels of C/EBP-b and
C/EBP-g mRNA are transiently increased. Similarly, ex-
pression levels of these transcription factors follow similar
patterns at 5 and 7 days after PH in SHPCs, perhaps
reflecting the intense proliferation occurring in this cell
compartment. This implies that certain transcription fac-
tors may have similar roles during liver regeneration in
both proliferating SHPCs and normal hepatocytes. The
significance of increased levels of mRNA for HNF-3 and
HNF-4 in early-appearing SHPCs is currently unknown,
though it is possible to imagine some role for these tran-
scription factors in the proliferation, maturation, and/or
differentiation of these cells. However, because many
genes expressed in the liver are capable of being regu-
lated by multiple transcription factors (and other fac-
tors)59 and none of the transcription factors mentioned
thus far are capable of starting a hepatocyte differentia-
tion program by themselves,60 the precise consequence
of relative levels of liver-enriched transcription factor
mRNA in SHPCs is currently unknown.
Although many markers of hepatocyte differentiation
are already present on early SHPCs (and E14 bipotential
hepatoblasts), there is a conspicuous lack of mRNA
and/or protein expression of hepatocyte markers whose
expression is initiated at or later than E18–20 by some (or
all) SHPCs. SHPCs at 5 days after PH completely lack
mRNA expression of TAT, a marker of fully differentiated
hepatocytes whose expression is not detected before
birth.61 However, it is not clear why SHPCs cells lack
expression of a-1 AT at this time point, because this
mRNA is detected as early as E13 in fetal mouse liver.62
The lack of CYP 2E1 and CYP 3A1 protein expression
(and concurrent robust expression of CYP 2B1/2, albu-
min, and transferrin) by a substantial number of SHPCs at
5 days after PH further substantiates the “transitional”
nature of proliferating SHPCs, because CYP 2E1 and
CYP 3A1 are not detected until near or at the time of birth
in the rat.41,63–66 Furthermore, SHPCs display transient
expression between 5 and 7 days after PH of two anti-
gens recognized by the monoclonal antibodies OC.267,68
and OC.593 which are historically used to identify oval
cells and bile duct epithelial cells and study cell lineage
relationships in developing liver.15 The cytoplasmic dis-
tribution of the multidrug transporter Pgp42,69–71 in the
earliest (most primitive) clusters of SHPCs at 3 days after
PH suggests that these cells are initiating expression of
this protein for the first time, because Pgp is rapidly
localized to the bile canalicular membrane (as in fully
differentiated hepatocytes) by 5 days after PH.
The results of the current study indicate that continued
expression of AFP and WT1 5 days after PH by SHPCs
(and the concordant lack of expression of certain hepa-
tocyte markers, such as CYP 3A1) further distinguishes
these cells phenotypically and morphologically from oval
cells, bile duct epithelial cells, and fully differentiated
hepatocytes (megalocytes) in the retrorsine/PH model.
The fact that retrorsine-injured hepatocytes are weakly
and transiently AFP mRNA- and protein-positive is not
surprising. It is well known that under certain conditions
(such as chemical injury), the liver is capable of reinitiat-
ing expression of AFP (summarized in ref. 17). Interest-
ingly, Dabeva and colleagues17 have noted AFP expres-
sion patterns in retrorsine-exposed livers after PH
(concurrent with transplantation of isolated hepatocytes)
that differ from the results presented here. These inves-
tigators observe substantially elevated levels of AFP
mRNA (using in situ hybridization) in extensively prolifer-
ated oval cells of retrorsine-exposed livers after PH. In the
absence of transplanted hepatocytes, we report here that
the few oval cells that emerged after PH in these livers15
were essentially AFP-negative (Figure 5E). Furthermore,
Dabeva and colleagues did not observe AFP mRNA in
well-circumscribed clusters of proliferating endogenous
small hepatocytes, although small hepatocytes/transi-
tional cells that colocalized with oval cells were AFP-
positive.17 It is plausible that the endogenous small hepa-
tocytes characterized by Dabeva and colleagues are
members of the SHPC compartment we describe here
and elsewhere,15 because the transplantation of hepato-
cytes concurrent with PH by these authors represents a
substantial departure from the experimental design of the
current study. It is possible that the endogenous small
hepatocyte compartment in rodent liver reacts differently
in retrorsine-exposed rats receiving isolated normal he-
patocyte cell transplantation from those not receiving cell
transplants.
The expression of moderate levels of WT1 protein by
SHPCs during the early phase of liver regeneration is
intriguing. WT1 is expressed in a spatial and temporal
manner during urogenital development and is best
known for its role as a tumor suppressor.45 Although WT1
is not normally expressed in hepatocytes, we (and oth-
ers)38 have previously shown that WT1 mRNA and pro-
tein are present in WB-F344 cells.46 WB-F344 cells are a
line of undifferentiated liver epithelial stemlike cells (orig-
inally isolated from a normal rat) capable of hepatocytic
differentiation on transplantation into the livers of host
rats.72,73 Furthermore, WT1 protein is localized mainly to
the nucleus in these cells in vitro (unpublished observa-
tions). The fact that a subset of SHPCs (;5%) maintain
nuclear-localized WT1 expression through the early
phase of liver regeneration in this model may suggest
that as the SHPC population proliferates and differenti-
ates, there is maintenance of a more “stemlike” subset of
cells in this compartment until such time when it is no
longer needed. However, the precise role of WT1 protein
in SHPCs is not understood at this point. WT1 may inter-
act with genes and/or proteins that are important in the
regulation of liver growth and differentiation, inasmuch as
WT1 has been shown to regulate many growth-related
genes.74–77 WT1 is also responsible for the onset of
epithelial differentiation (via repression of bcl-2 and
c-myc) during renal development.78 Potential targets of
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WT1-induced transcriptional repression in highly prolifer-
ative SHPCs could include transforming growth factor-
b,76 because this growth factor is a negative regulator of
proliferation in rodent hepatocytes after PH.79
The resistance of oval cells to a number of different
carcinogens, many of which are mitoinhibitory to mature
hepatocytes (such as 2-acetylaminofluorene), is due to
the absence of carcinogen-activated CYPs.9,80–82 Oval
cells that proliferate in these models lack expression of
CYP enzymes when they first appear.9 However, these
cells initiate expression of CYP enzymes when they dif-
ferentiate and form foci of small basophilic hepatocytes.7
At the dose used in the current study, retrorsine induces
the expression of mRNA and/or protein for CYP 2E1, CYP
2B1/2, CYP 1A2, and CYP 1A1.83 Other laboratories have
also implicated CYP 3A1 in the bioactivation of other
retrorsine-related family members to their active metab-
olites.84–86 These findings and the results of the current
study, showing reduced (or complete lack of) expression
of CYP 2E1 and CYP 3A1 mRNA and/or protein by
SHPCs, combine to strongly suggest that the earliest
appearing SHPCs (or their ultimate progenitor) escape
the mitoinhibitory effects of retrorsine because they lack
or have reduced expression of one or more of the CYPs
required for the bioactivation of this pyrrolizidiue alkyloid.
Unlike most enzymes, which possess relatively high sub-
strate specificity, CYPs are capable of metabolizing a
number of structurally diverse compounds.87,88 In addi-
tion, it is possible for a compound to be a CYP substrate
in the absence of increased levels of CYP mRNA and/or
protein.88 Thus the fact that we did not previously detect
enhanced mRNA or protein levels for CYP 3A1 after
retrorsine exposure83 does not necessarily exclude CYP
3A1 from playing a role in the bioactivation of retrorsine.
Various liver-enriched transcription factors (the mRNAs of
which are expressed by SHPCs), such as HNF-1, HNF-3,
HNF-4, and C/EBP, have been implicated in the regula-
tion of the expression of CYP genes.89 As such, the
reason for decreased levels of CYP 3A1 and CYP 2E1
protein in cells of early SHPC clusters is not clear, but
could involve mechanisms of posttranscriptional regula-
tion. Even though CYP 3A1 mRNA is detected as early as
E15 in developing liver,64 CYP 3A1 protein cannot be
detected until a day or two before birth.66 Likewise, nei-
ther CYP 2E1 mRNA or protein can be detected in rat
livers until after birth, likely because of methylation-re-
lated chromatin accessibility issues.90
In summary, the results of this study and previous
observations15 combine to suggest 1) that SHPCs repre-
sent a previously uncharacterized parenchymal progenitor
cell population of adult rodent liver that is phenotypically
and/or morphologically distinct from fully differentiated
hepatocytes, biliary epithelial cells, and oval cells; 2) that
SHPCs escape the mitoinhibitory effects of retrorsine be-
cause they lack the appropriate CYP enzymes needed to
produce toxic retrorsine metabolites; and 3) that the earliest
progenitor cells for emerging SHPC clusters are found
within the hepatic parenchyma (and not in portal spaces)
and could possibly be identified by the expression of AFP
and/or (nuclear-localized) WT protein.
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